ImmuCell Corporation Earning Date (ICCC)

USA |NASDAQ |USD

ICCC Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Feb 21, 2022 Dec 2021 - - $0.03
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Feb 21, 2022 Dec 2021 - $5.15M $3.74M

Immucell Corporation's next earnings date is Monday, Feb 21, 2022 for the fiscal quarter ending Dec 2021.

ICCC Earnings Date & History Chart

ICCC Earnings & Revenue Forecast

ICCC Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 0 $0.00 $0.00 $0.00
Dec 2022 0 $0.00 $0.00 $0.00

ICCC Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-0.11 $-0.11 $-0.11
Dec 2022 0 / 0 $0.00 $0.00 $0.00

ICCC Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 1 $16.65M $16.65M $16.65M
Dec 2022 0 $0.00 $0.00 $0.00

ICCC Earnings Date & Revenue History

ICCC Earnings History

|
Show More
Show More

ICCC Revenue History

|
Show More
Show More

Immucell Corporation Next Earnings Date & Report

ICCC Next Earnings Date & Report Preview: Dec 2021 (FQ)

ICCC's next earnings date is Monday, Feb 21, 2022 for the fiscal quarter ending Dec 31, 2021.

Immucell Corporation Previous Earnings Dates & Reports

ICCC Previous Earnings Date & Report Recap: Sep 2021 (FQ)

Immucell Corporation's previous earnings date was Nov 15, 2021 for its fiscal quarter ended Sep 30, 2021.

Revenues were $5.15M, up by 13.39% from the previous quarter , and up by 38.35% from the same period last year.

The company reported a net income of $148.00K.

Free cash flow for the quarter was $-1.54M , compared to $-148.51K last quarter and $-2.14M a year before.

ICCC ended the quarter with $9.71M in total debt, a decrease of -5.80% compared to the previous quarter, and a decrease of -1.06% compared to the same quarter a year before.

ICCC Previous Earnings Date & Report Recap: Dec 2020 (FY)

Immucell Corporation's previous annual earnings date was Feb 22, 2021 for its fiscal year ended Dec 31, 2020.

ICCC's earnings per share (EPS) was $-0.14, missing the consensus analysts forecast of $0.00 by % , and higher than the previous year's EPS (Dec 2019) by -27.32%.

Revenues were $15.34M, better than the forecast of $15.14M by 1.33%, and up by 11.80% from previous year's revenue.

The company reported a net income of $-1.02M.

Immucell Corporation reported a free cash flow of $-2.76M for its fiscal year, compared to $-1.16M a year ago.

The company ended the fiscal year with $10.26M in total debt, an increase of 21.81% compared to the previous year.